Yonsei Med J.  2013 May;54(3):583-589. 10.3349/ymj.2013.54.3.583.

Prevalence and Clinical Factors of Anxiety and Depression in Neurally Mediated and Unexplained Syncope

• Lee SH
• Park SJ
• Byeon K
• On YK
• Yim HR
• Kim JS

• KMID: 1727868
• DOI: http://doi.org/10.3349/ymj.2013.54.3.583

Abstract

PURPOSE
Several studies have demonstrated that psychiatric disorders such as anxiety, depression and panic attack are associated with syncope, especially vasovagal and unexplained syncope (US). The aim of this study was to compare the prevalence of anxiety and depression between patients with neurally mediated syncope (NMS) and US and to investigate the clinical factors associated with anxiety and depression.
MATERIALS AND METHODS
Between January 2009 and March 2010, 383 patients with syncopal episodes completed a Hospital Anxiety and Depression Scale questionnaire to assess symptoms of anxiety and depression. Inclusion criteria were NMS and US. Exclusion criteria were cardiac syncope, orthostatic hypotension and other disorders mimicking syncope. After exclusion, 199 patients were included.
RESULTS
There were 176 (88.4%) NMS patients and 23 (11.6%) US patients. The prevalence of abnormal anxiety and depression were not significantly different between the NMS and US groups (10.2% vs. 8.7%, p=0.99; 8.5% vs. 17.4%, p=0.24). Clinical factors associated with anxiety were female gender (p=0.01) and six or more recurrent syncopal episodes (p=0.01) by univariate analysis. The only factor associated with abnormal anxiety score (OR=20.26, 95% CI: 1.4-291.6, p=0.01) was more than six recurrent syncopal episodes, while a positive head-up tilt table testing response was inversely associated with abnormal depression score (OR=0.28, CI: 0.08-0.97, p=0.04) in the multiple logistic regression analysis.
CONCLUSION
Anxiety was associated with frequent syncopal episodes. Thus, anxiety might be considered in the management of syncope patients.

Keyword

Anxiety; depression; syncope

MeSH Terms

Adolescent
Adult
Aged
Anxiety/complications/*epidemiology
Depression/complications/*epidemiology
Female
Humans
Logistic Models
Male
Middle Aged
Prevalence
Republic of Korea/epidemiology
Sex Factors
Syncope, Vasovagal/complications/*psychology
Tilt-Table Test

Reference

1. Savage DD, Corwin L, McGee DL, Kannel WB, Wolf PA. Epidemiologic features of isolated syncope: the Framingham Study. Stroke. 1985. 16:626–629.

2. Ganzeboom KS, Mairuhu G, Reitsma JB, Linzer M, Wieling W, van Dijk N. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol. 2006. 17:1172–1176.

3. Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol. 1991. 44:1037–1043.

4. McGrady A, Kern-Buell C, Bush E, Khuder S, Grubb BP. Psychological and physiological factors associated with tilt table testing for neurally mediated syncopal syndromes. Pacing Clin Electrophysiol. 2001. 24:296–301.

5. Cohen TJ, Thayapran N, Ibrahim B, Quan C, Quan W, von zur Muhlen F. An association between anxiety and neurocardiogenic syncope during head-up tilt table testing. Pacing Clin Electrophysiol. 2000. 23:837–841.

6. D'Antono B, Dupuis G, St-Jean K, Lévesque K, Nadeau R, Guerra P, et al. Prospective evaluation of psychological distress and psychiatric morbidity in recurrent vasovagal and unexplained syncope. J Psychosom Res. 2009. 67:213–222.

7. Giada F, Silvestri I, Rossillo A, Nicotera PG, Manzillo GF, Raviele A. Psychiatric profile, quality of life and risk of syncopal recurrence in patients with tilt-induced vasovagal syncope. Europace. 2005. 7:465–471.

8. Kouakam C, Lacroix D, Klug D, Baux P, Marquié C, Kacet S. Prevalence and prognostic significance of psychiatric disorders in patients evaluated for recurrent unexplained syncope. Am J Cardiol. 2002. 89:530–535.

9. Ventura R, Maas R, Rüppel R, Stuhr U, Schuchert A, Meinertz T, et al. Psychiatric conditions in patients with recurrent unexplained syncope. Europace. 2001. 3:311–316.

10. Flint B, Baker C, Freeston M, Newton JL. Level of psychosocial impairment predicts early response to treatment in vasovagal syncope. Europace. 2009. 11:231–236.

11. Task Force for the Diagnosis and Management of Syncope. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA). Heart Failure Association (HFA). Heart Rhythm Society (HRS). Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009. 30:2631–2671.

12. Brignole M, Menozzi C, Gianfranchi L, Oddone D, Lolli G, Bertulla A. Carotid sinus massage, eyeball compression, and head-up tilt test in patients with syncope of uncertain origin and in healthy control subjects. Am Heart J. 1991. 122:1644–1651.

13. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983. 67:361–370.

14. Yun YH, Kim SH, Lee KM, Park SM, Kim YM. Age, sex, and comorbidities were considered in comparing reference data for health-related quality of life in the general and cancer populations. J Clin Epidemiol. 2007. 60:1164–1175.

15. Kapoor WN, Fortunato M, Hanusa BH, Schulberg HC. Psychiatric illnesses in patients with syncope. Am J Med. 1995. 99:505–512.

16. Gracie J, Newton JL, Norton M, Baker C, Freeston M. The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncope. Europace. 2006. 8:636–643.

17. Linzer M, Varia I, Pontinen M, Divine GW, Grubb BP, Estes NA 3rd. Medically unexplained syncope: relationship to psychiatric illness. Am J Med. 1992. 92:18S–25S.

18. Linzer M, Felder A, Hackel A, Perry AJ, Varia I, Melville ML, et al. Psychiatric syncope: a new look at an old disease. Psychosomatics. 1990. 31:181–188.

19. Runkewitz K, Kirchmann H, Strauss B. Anxiety and depression in primary care patients: predictors of symptom severity and developmental correlates. J Psychosom Res. 2006. 60:445–453.